Human CD99 Antibody
R&D Systems, part of Bio-Techne | Catalog # AF3968
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Asp23-Asp122
Accession # P14209
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human CD99 Antibody
Detection of Human CD99 by Western Blot.
Western blot shows lysates of NCI-H460 human large cell lung carcinoma cell line, U251-MG human malignant glioblastoma cell line, amd SK-Mel-28 human malignant melanoma cell line. PVDF membrane was probed with 0.25 µg/mL of Goat Anti-Human CD99 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3968) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF017). A specific band was detected for CD99 at approximately 32 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.Detection of CD99 in Human CD3+Lymphocytes by Flow Cytometry.
Human whole blood CD3+lymphocytes were stained with Goat Anti-Human CD99 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3968, filled histogram) or control antibody (Catalog # AB-108-C, open histogram), followed by Phycoerythrin-conjugated Anti-Goat IgG Secondary Antibody (Catalog # F0107).CD99 in HepG2 Human Cell Line.
CD99 was detected in immersion fixed HepG2 human hepatocellular carcinoma cell line using Goat Anti-Human CD99 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3968) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). Specific staining was localized to cell membranes. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.Applications for Human CD99 Antibody
CyTOF-ready
Flow Cytometry
Sample: Human whole blood CD3+ lymphocytes
Immunocytochemistry
Sample: Immersion fixed HepG2 human hepatocellular carcinoma cell line
Simple Western
Sample: MOLT‑4 human acute lymphoblastic leukemia cell line
Western Blot
Sample: NCI‑H460 human large cell lung carcinoma cell line, U251-MG human malignant glioblastoma cell line, amd SK‑Mel‑28 human malignant melanoma cell line
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CD99
CD99 (also named MIC2, E2 and thymic leukemia antigen) is the founding member of the CD99 family of molecules. The CD99 family contains four members; CD99, CD99L2, XG and the pseudogene CD99L1 (1, 2, 3). Native human CD99 is 32 kDa in size and exists as a type I transmembrane glycoprotein. This is referred to as the long, or type I isoform. It is synthesized as a 185 amino acid (aa) precursor that contains a 22 aa signal sequence, a 100 aa extracellular domain (ECD), a 25 aa transmembrane segment, and a 38 aa cytoplasmic region (4). The ECD contains no identifiable motifs, N‑linked glycosylation sites, or cysteine residues; it does possess sites for O-linked glycosylation. The cytoplasmic region, albeit short, does have signal transduction capability (5). There are apparently multiple isoforms for human CD99. One shows a 16 aa deletion in the ECD (aa 34‑49), a second shows a 38 aa deletion in the cytoplasmic region (aa 122‑159), and a third exhibits a three aa truncation at the C-terminus (6, 7, 8). The best studied isoform shows an Asp‑Gly substitution for the C‑terminal 27 amino acids. This is referred to as the 28 kDa type II isoform (9). The type I and II isoforms have distinctive signal transduction pathways (FAK-src for type I; PI3K plus src-ERK1/2 for type II), and mediate clearly different biological outcomes (5, 9, 10). The two numbered isoforms may or may not co‑exist on the same cells. Peripheral T cells have only the long isoform, while double-positive thymocytes express both isotypes. What is unclear is the monomeric vs. dimeric status of CD99. In mouse, CD99 reportedly forms disulfide-linked homodimers (11). In human, however, CD99 is reportedly monomeric if only a type I isoform, and a covalent heterodimer if co‑expressing type I and II isoforms (12, 13). Cells known to express CD99 include fibroblasts, neutrophils, T cells, double-positive thymocytes, CD34+ stem cells, monocytes and endothelial cells (2, 12, 14, 15). Homophilic interaction between CD99 on the neutrophil and CD99 on the endothelial cell regulates the transendothelial migration of neutrophils during inflammation (16). Human CD99 is only 48% aa identical to mouse CD99 (17).
References
- Wilson, M.D. et al. (2006) Physiol Genomics 27:201.
- Petri, B. and M.G. Bixel (2006) FEBS J. 273:4399.
- Suh, Y.H. et al. (2003) Gene 307:63.
- Gelin, C. et al. (1989) EMBO J. 8:3253.
- Byun, H-J. et al. (2006) J. Biol. Chem. 281:34833.
- GenBank Accession # EAW98698.
- GenBank Accession # EAW98699.
- GenBank Accession # EAW98700.
- Hahn, H-J. et al. (1997) J. Immunol. 159:2250.
- Scotlandi, K. et al. (2007) Oncogene Apr 30; [Epub ahead of print].
- Park, S.H. et al. (2005) Gene 353:177.
- Schenkel, A.R. et al. (2002) Nat. Immunol. 3:143.
- Alberti, I. et al. (2002) FASEB J. 16:1946.
- Imbert, A-M. et al. (2006) Blood 108:2578.
- Dworzak, M.N. et al. (1994) Blood 83:415.
- Lou, O. et al. (2007) J. Immunol. 178:1136
- Shiratori, I. et al. (2004) J. Exp. Med. 199:525.
Alternate Names
Gene Symbol
UniProt
Additional CD99 Products
Product Documents for Human CD99 Antibody
Product Specific Notices for Human CD99 Antibody
For research use only